← Browse by Condition
Medical Condition
autoimmune diseases of the nervous system
Total Trials
3
Recruiting Now
3
Trial Phases
Various
ClinicalMetric tracks all active clinical trials for autoimmune diseases of the nervous system sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Top Sponsors
1 trial
1 trial
1 trial
NCT05214612
Recruiting
Predictors and Prognostic Factors of Myasthenia Gravis Outcome
Enrollment
30 pts
Location
Egypt
Sponsor
Assiut University
NCT04786821
Recruiting
Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple Sclerosis
Enrollment
24 pts
Location
United Kingdom
Sponsor
Sheffield Teaching Hospitals N...
NCT06502015
Recruiting
Biomarkers in Autoimmune Disease of Nervous System
Enrollment
50,000 pts
Location
China
Sponsor
Tongji Hospital
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology